STOCK TITAN
  1. Home
  2. Sec-filings
  3. THC
  4. [Form 4] TENET HEALTHCARE CORP Insider Trading Activity

Tenet Healthcare (NYSE: THC) CEO reports RSU grants and tax share withholding

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Tenet Healthcare CEO Saumya Sutaria reported several equity compensation events involving restricted stock units and common shares. He received a grant of 36,092 2026 February restricted stock units that convert into common stock on a one-for-one basis and vest in one-third increments over three years. Previously granted RSUs from 2023 and 2024 vested, with 22,417 and 36,384 units exercised into common stock on February 27, 2026. To cover withholding taxes tied to performance and restricted stock unit vesting, he disposed of 9,282 common shares at $237.58 and 29,919 and 124,959 shares at $239.39 through tax-withholding transactions, not open-market sales. After these movements, Sutaria directly owned 658,523 shares of Tenet Healthcare common stock.

Positive

  • None.

Negative

  • None.
Insider Sutaria Saumya
Role CEO
Type Security Shares Price Value
Grant/Award 2026 February Restricted Stock Units 36,092 $0.00 --
Exercise 2024 February Restricted Stock Units 22,417 $0.00 --
Exercise 2023 March Restricted Stock Units 36,384 $0.00 --
Exercise Common Stock 22,417 $0.00 --
Exercise Common Stock 36,384 $0.00 --
Tax Withholding Common Stock 9,282 $237.58 $2.21M
Tax Withholding Common Stock 29,919 $239.39 $7.16M
Tax Withholding Common Stock 124,959 $239.39 $29.91M
Holdings After Transaction: 2026 February Restricted Stock Units — 36,092 shares (Direct); 2024 February Restricted Stock Units — 22,417 shares (Direct); 2023 March Restricted Stock Units — 0 shares (Direct); Common Stock — 661,340 shares (Direct)
Footnotes (1)
  1. Restricted stock units convert into common stock on a one-for-one basis. Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units. Represents the closing price of the common stock of the Issuer on the vesting date for the award. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Represents the closing price of the common stock of the Issuer on February 27, 2026. These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 28, 2024, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment vested on February 27, 2026 (the business day prior to February 28, 2026, which fell on a weekend). Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third 1/3 increment vested on February 27, 2026 (the business day prior to March 1, 2026, which fell on a weekend).
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sutaria Saumya
(Last) (First) (Middle)
14201 DALLAS PARKWAY
(Street)
DALLAS TX 75254
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CEO
3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/27/2026 M 22,417 A (1) 661,340 D
Common Stock 02/27/2026 M 36,384 A (1) 697,724 D
Common Stock 02/27/2026 F 9,282(2) D $237.58(3) 688,442 D
Common Stock 02/27/2026 F 29,919(4) D $239.39(5) 658,523 D
Common Stock 02/27/2026 F 124,959(2) D $239.39(5) 533,564 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
2026 February Restricted Stock Units (6) 02/27/2026 A 36,092 (6) (6) Common Stock 36,092 $0 36,092 D
2024 February Restricted Stock Units (7) 02/27/2026 M 22,417 (7) (7) Common Stock(8) 22,417 $0 22,417 D
2023 March Restricted Stock Units (9) 02/27/2026 M 36,384 (9) (9) Common Stock(8) 36,384 $0 0 D
Explanation of Responses:
1. Restricted stock units convert into common stock on a one-for-one basis.
2. Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units.
3. Represents the closing price of the common stock of the Issuer on the vesting date for the award.
4. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
5. Represents the closing price of the common stock of the Issuer on February 27, 2026.
6. These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting.
7. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 28, 2024, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment vested on February 27, 2026 (the business day prior to February 28, 2026, which fell on a weekend).
8. Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.
9. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third 1/3 increment vested on February 27, 2026 (the business day prior to March 1, 2026, which fell on a weekend).
Chad J. Wiener, as Attorney-in-fact for Saumya Sutaria 03/03/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Tenet Healthcare (THC) CEO Saumya Sutaria report?

Saumya Sutaria reported equity compensation transactions, including RSU grants, vesting, and related tax share withholding. He received new 2026 RSUs, converted vested 2023 and 2024 RSUs into common stock, and delivered shares to cover withholding taxes tied to these awards.

How many new restricted stock units did the Tenet (THC) CEO receive?

The CEO received a grant of 36,092 2026 February restricted stock units. These units convert into common stock on a one-for-one basis and vest in one-third installments on each of the first three anniversaries of the grant date, under Tenet’s 2019 Stock Incentive Plan.

What RSU vesting and conversions were reported in this Tenet (THC) Form 4?

Previously granted RSUs from 2024 and 2023 vested and were exercised into common stock. One award converted 22,417 restricted stock units, and another converted 36,384 units, both settling in Tenet common shares as scheduled under the 2019 Stock Incentive Plan.

Were the Tenet (THC) CEO’s reported share dispositions open-market sales?

No, the reported share dispositions were for tax withholding purposes. Footnotes state that shares were delivered or withheld to satisfy tax liabilities upon vesting of performance and restricted stock units, using the issuer’s closing stock price on the relevant vesting date.

At what prices were Tenet (THC) shares used for tax withholding in this filing?

Common shares were withheld at $237.58 and $239.39 per share. These prices represent the issuer’s closing stock price on the relevant vesting dates, as noted in the footnotes, and were used to determine the value of shares delivered for tax obligations.

How many Tenet (THC) common shares does the CEO own after these transactions?

After the reported RSU conversions and tax-withholding dispositions, Saumya Sutaria directly owned 658,523 shares of Tenet Healthcare common stock. This figure reflects his direct beneficial ownership immediately following completion of the transactions reported in the Form 4.

How do Tenet (THC) time-based RSUs vest for the CEO’s awards?

Time-based restricted stock units granted in 2023 and 2024 vest in equal one-third increments on the first, second, and third anniversaries of the grant date. Upon each vesting, the RSUs are settled in shares of Tenet Healthcare’s common stock on a one-for-one basis.